Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier
- 1 January 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5), 766-770
- https://doi.org/10.1016/0959-8049(94)00514-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- The tumor blood vessel as an ideal target for macromolecular anticancer agentsJournal of Controlled Release, 1992
- Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodolEuropean Journal Of Cancer, 1992
- Biodistribution of a monoclonal antibody (RNL-1) against the neural cell adhesion molecule (NCAM) in athymic mice bearing human small-cell lung-cancer xenograftsInternational Journal of Cancer, 1991
- SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapyAdvanced Drug Delivery Reviews, 1991
- Soluble Polymeric Carriers for Drug Delivery—Part 4: Tissue Autoradiography, and Whole-Body Tissue Distribution in Mice, of N-(2-Hydroxypropyl)Methacrylamide Copolymers Following Intravenous AdministrationJournal of Bioactive and Compatible Polymers, 1991
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987
- Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancsProtein Journal, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residuesBiochimica et Biophysica Acta (BBA) - General Subjects, 1983